Are you Dr. Lomeli?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 22 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
14500 S Quivira Rd
Olathe, KS 66062Phone+1 913-207-6463
Summary
- Dr. Barbara Lomeli, MD is an emergency medicine physician in Olathe, Kansas. She is currently licensed to practice medicine in Kansas, Florida, and New Mexico.
Education & Training
University of Missouri-Kansas City School of MedicineResidency, Emergency Medicine, 1981 - 1983
University of Iowa Hospitals and ClinicsInternship, Internal Medicine, 1980 - 1981
University of Kansas School of MedicineClass of 1980
Certifications & Licensure
FL State Medical License 2022 - 2025
KS State Medical License 1981 - 2025
NM State Medical License 2004 - 2004
Clinical Trials
- Auranofin PK Following Oral Dose Administration Start of enrollment: 2014 Apr 02
- Phase I Trial to Determine the Safety and Pharmacokinetics of CRS3123. Start of enrollment: 2014 Jun 01
- Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of PER977 Following Heparin Start of enrollment: 2014 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 194 citationsEdoxaban Effects on Bleeding Following Punch Biopsy and Reversal by a 4-Factor Prothrombin Complex ConcentrateHamim Zahir, Karen Brown, Alexander G. Vandell, Madhuri Desai, Jen-Fue Maa
Circulation. 2015-01-06 - 4 citationsEffect of cyclosporine coadministration on the pharmacokinetics of eltrombopag in healthy volunteersVassilios Aslanis, Jianping Zhang, Barbara K Lomeli, Kai Grosch, Taoufik Ouatas
Cancer Chemotherapy and Pharmacology. 2018-08-31 - 11 citationsMultiple-Ascending-Dose Phase 1 Clinical Study of the Safety, Tolerability, and Pharmacokinetics of CRS3123, a Narrow-Spectrum Agent with Minimal Disruption of Normal ...Barbara K Lomeli, Hal Galbraith, Jared Schettler, George A Saviolakis, Wael El-Amin
Antimicrobial Agents and Chemotherapy. 2019-12-20
